These findings suggest that TLR4 and ABCA1 may play crucial roles in controlling the immunological response to COVID-19 and AMI, presumably by activating metabolic, immune, and inflammatory pathways and by modulating the infiltration of specific immune cell types. The gene discussed is TLR4; the disease is COVID-19.